100 related articles for article (PubMed ID: 18307755)
1. Translational research goes both ways: lessons from clinical studies.
Funder JW
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):526-9. PubMed ID: 18307755
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology.
Funder JW; Mihailidou AS
Mol Cell Endocrinol; 2009 Mar; 301(1-2):2-6. PubMed ID: 19026715
[TBL] [Abstract][Full Text] [Related]
3. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
Baker ME; Funder JW; Kattoula SR
J Steroid Biochem Mol Biol; 2013 Sep; 137():57-70. PubMed ID: 23907018
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
Funder JW
Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone target organ protection by eplerenone.
Rudolph AE; Rocha R; McMahon EG
Mol Cell Endocrinol; 2004 Mar; 217(1-2):229-38. PubMed ID: 15134822
[TBL] [Abstract][Full Text] [Related]
6. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
Moore TD; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
[TBL] [Abstract][Full Text] [Related]
7. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
8. RALES, EPHESUS and redox.
Funder JW
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):121-5. PubMed ID: 15860254
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone as a cardiovascular risk factor.
Rossi G; Boscaro M; Ronconi V; Funder JW
Trends Endocrinol Metab; 2005 Apr; 16(3):104-7. PubMed ID: 15808807
[TBL] [Abstract][Full Text] [Related]
10. Towards selectively modulating mineralocorticoid receptor function: lessons from other systems.
Baxter JD; Funder JW; Apriletti JW; Webb P
Mol Cell Endocrinol; 2004 Mar; 217(1-2):151-65. PubMed ID: 15134814
[TBL] [Abstract][Full Text] [Related]
11. The evolution of mineralocorticoid receptors.
Hu X; Funder JW
Mol Endocrinol; 2006 Jul; 20(7):1471-8. PubMed ID: 16195247
[TBL] [Abstract][Full Text] [Related]
12. The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related.
Rafestin-Oblin ME; Souque A; Bocchi B; Pinon G; Fagart J; Vandewalle A
Endocrinology; 2003 Feb; 144(2):528-33. PubMed ID: 12538613
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
Galuppo P; Bauersachs J
Eur J Clin Invest; 2012 Oct; 42(10):1112-20. PubMed ID: 22536780
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone, hypertension and heart failure: insights from clinical trials.
Funder JW
Hypertens Res; 2010 Sep; 33(9):872-5. PubMed ID: 20631715
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone, mineralocorticoid receptor, and heart failure.
Messaoudi S; Azibani F; Delcayre C; Jaisser F
Mol Cell Endocrinol; 2012 Mar; 350(2):266-72. PubMed ID: 21784127
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line.
Gaeggeler HP; Gonzalez-Rodriguez E; Jaeger NF; Loffing-Cueni D; Norregaard R; Loffing J; Horisberger JD; Rossier BC
J Am Soc Nephrol; 2005 Apr; 16(4):878-91. PubMed ID: 15743993
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific effects of spironolactone on blood pressure in gonadectomized male and female Wistar rats.
Michaelis M; Hofmann PJ; Götz F; Bartel C; Kienitz T; Quinkler M
Horm Metab Res; 2012 Apr; 44(4):291-5. PubMed ID: 22266825
[TBL] [Abstract][Full Text] [Related]
18. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?
Chai W; Hofland J; Jansen PM; Garrelds IM; de Vries R; van den Bogaerdt AJ; Feelders RA; de Jong FH; Danser AH
J Hypertens; 2010 May; 28(5):1044-53. PubMed ID: 20179635
[TBL] [Abstract][Full Text] [Related]
19. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease.
Pitt B; Stier CT; Rajagopalan S
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):164-8. PubMed ID: 14608520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
